古巴成功应对疫情的背后。 - Suppr

Suppr

超能文献

Behind Cuba's successful pandemic response.

作者信息

Burki Talha

出版信息

Lancet Infect Dis. 2021 Apr;21(4):465-466. doi: 10.1016/S1473-3099(21)00159-6.

DOI:10.1016/S1473-3099(21)00159-6

PMID:33773131

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7990484/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd80/7990484/e06f7bb1202a/fx1_lrg.jpg

相似文献

Behind Cuba's successful pandemic response.

Lancet Infect Dis. 2021 Apr;21(4):465-466. doi: 10.1016/S1473-3099(21)00159-6.

Challenges in the rollout of COVID-19 vaccines worldwide.

Lancet Respir Med. 2021 Apr;9(4):e42-e43. doi: 10.1016/S2213-2600(21)00129-6. Epub 2021 Mar 5.

Key steps in our journey to a COVID-19 vaccine program.

Med J Aust. 2021 Apr;214(6):249-251.e1. doi: 10.5694/mja2.50978. Epub 2021 Mar 21.

COVID-19 Vaccine Development to Vaccination.

J Nepal Health Res Counc. 2021 Jan 22;18(4):807-809. doi: 10.33314/jnhrc.v18i4.3351.

Monoclonal Antibodies vs COVID-19: Eduardo Ojito-Magaz MS General Director, Molecular Immunology Center.

MEDICC Rev. 2021 Apr;23(2):12. doi: 10.37757/MR2021.V23.N2.17. Epub 2021 Apr 30.

COVID-19 in the Caribbean.

Lancet Respir Med. 2021 Apr;9(4):e46. doi: 10.1016/S2213-2600(21)00090-4. Epub 2021 Feb 11.

SOBERANA, Cuba's COVID-19 Vaccine Candidates: Dagmar García-Rivera PhD.

MEDICC Rev. 2020 Oct;22(4):10-15. doi: 10.37757/MR2020.V22.N4.11.

Not in my backyard: COVID-19 vaccine development requires someone to be infected somewhere.

Med J Aust. 2021 Mar;214(4):150-152.e1. doi: 10.5694/mja2.50930. Epub 2021 Feb 7.

A patent waiver on COVID vaccines is right and fair.

Nature. 2021 May;593(7860):478. doi: 10.1038/d41586-021-01242-1.

[Fight against COVID-19: market overview and pipeline of ongoing trials].

Med Sci (Paris). 2020 Dec;36(12):1225-1232. doi: 10.1051/medsci/2020231. Epub 2020 Nov 19.

引用本文的文献

Long COVID Syndrome: A Narrative Review on Burden of Age and Vaccination.

J Clin Med. 2024 Aug 13;13(16):4756. doi: 10.3390/jcm13164756.

Decolonizing a Wretched Healthcare System: The African Public Health Practitioner Case.

Ethn Dis. 2024 May 27;34(1):49-52. doi: 10.18865/ed.34.1.49. eCollection 2024 Jan.

Perceived stress during COVID-19: Community resilience three years before the pandemic as a protective factor.

Int J Disaster Risk Reduct. 2022 Nov;82:103337. doi: 10.1016/j.ijdrr.2022.103337. Epub 2022 Oct 4.

International Efforts and Next Steps to Advance COVID-19 Vaccines Research and Production in Low- and Middle-Income Countries.

Vaccines (Basel). 2021 Dec 29;10(1):42. doi: 10.3390/vaccines10010042.

HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis.

Euroasian J Hepatogastroenterol. 2021 Jul-Dec;11(2):59-70. doi: 10.5005/jp-journals-10018-1344.

The politics of COVID-19 vaccination in middle-income countries: Lessons from Brazil.

Soc Sci Med. 2021 Jul;281:114093. doi: 10.1016/j.socscimed.2021.114093. Epub 2021 Jun 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Behind Cuba's successful pandemic response.

Lancet Infect Dis. 2021 Apr;21(4):465-466. doi: 10.1016/S1473-3099(21)00159-6.

Challenges in the rollout of COVID-19 vaccines worldwide.

Lancet Respir Med. 2021 Apr;9(4):e42-e43. doi: 10.1016/S2213-2600(21)00129-6. Epub 2021 Mar 5.

Key steps in our journey to a COVID-19 vaccine program.

Med J Aust. 2021 Apr;214(6):249-251.e1. doi: 10.5694/mja2.50978. Epub 2021 Mar 21.

COVID-19 Vaccine Development to Vaccination.

J Nepal Health Res Counc. 2021 Jan 22;18(4):807-809. doi: 10.33314/jnhrc.v18i4.3351.

Monoclonal Antibodies vs COVID-19: Eduardo Ojito-Magaz MS General Director, Molecular Immunology Center.

MEDICC Rev. 2021 Apr;23(2):12. doi: 10.37757/MR2021.V23.N2.17. Epub 2021 Apr 30.

COVID-19 in the Caribbean.

Lancet Respir Med. 2021 Apr;9(4):e46. doi: 10.1016/S2213-2600(21)00090-4. Epub 2021 Feb 11.

SOBERANA, Cuba's COVID-19 Vaccine Candidates: Dagmar García-Rivera PhD.

MEDICC Rev. 2020 Oct;22(4):10-15. doi: 10.37757/MR2020.V22.N4.11.

Not in my backyard: COVID-19 vaccine development requires someone to be infected somewhere.

Med J Aust. 2021 Mar;214(4):150-152.e1. doi: 10.5694/mja2.50930. Epub 2021 Feb 7.

A patent waiver on COVID vaccines is right and fair.

Nature. 2021 May;593(7860):478. doi: 10.1038/d41586-021-01242-1.

[Fight against COVID-19: market overview and pipeline of ongoing trials].

Med Sci (Paris). 2020 Dec;36(12):1225-1232. doi: 10.1051/medsci/2020231. Epub 2020 Nov 19.

引用本文的文献

Long COVID Syndrome: A Narrative Review on Burden of Age and Vaccination.

J Clin Med. 2024 Aug 13;13(16):4756. doi: 10.3390/jcm13164756.

Decolonizing a Wretched Healthcare System: The African Public Health Practitioner Case.

Ethn Dis. 2024 May 27;34(1):49-52. doi: 10.18865/ed.34.1.49. eCollection 2024 Jan.

Perceived stress during COVID-19: Community resilience three years before the pandemic as a protective factor.

Int J Disaster Risk Reduct. 2022 Nov;82:103337. doi: 10.1016/j.ijdrr.2022.103337. Epub 2022 Oct 4.

International Efforts and Next Steps to Advance COVID-19 Vaccines Research and Production in Low- and Middle-Income Countries.

Vaccines (Basel). 2021 Dec 29;10(1):42. doi: 10.3390/vaccines10010042.

HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis.

Euroasian J Hepatogastroenterol. 2021 Jul-Dec;11(2):59-70. doi: 10.5005/jp-journals-10018-1344.

The politics of COVID-19 vaccination in middle-income countries: Lessons from Brazil.

Soc Sci Med. 2021 Jul;281:114093. doi: 10.1016/j.socscimed.2021.114093. Epub 2021 Jun 2.